healiva®
Healiva is a patient-centric biotech company developing innovative, personalized, and affordable therapies for chronic wound care. They focus on advancing cutting-edge solutions to improve patient outcomes and redefine wound healing, addressing the significant burden of non-healing chronic wounds worldwide.
Industries
Nr. of Employees
small (1-50)
Products
Epidermal cell graft therapy for severe chronic wounds
Patient-personalized epidermal cell graft approach intended for treatment of severe or non-healing chronic wounds.
Enzymatic debridement formulation for wound cleaning
Enzyme-based topical agent designed to debride and prepare wound beds for subsequent therapeutic interventions.
Allogeneic cell spray for chronic wound treatment
Topical allogeneic cell suspension delivery format intended to stimulate growth factors and support healing in chronic wounds with scalable manufacturing potential.
Autologous blood-derived patch prepared at point of care
A therapy workflow for preparing an autologous blood patch at point of care by healthcare professionals for application to chronic wounds.
Epidermal cell graft therapy for severe chronic wounds
Patient-personalized epidermal cell graft approach intended for treatment of severe or non-healing chronic wounds.
Enzymatic debridement formulation for wound cleaning
Enzyme-based topical agent designed to debride and prepare wound beds for subsequent therapeutic interventions.
Allogeneic cell spray for chronic wound treatment
Topical allogeneic cell suspension delivery format intended to stimulate growth factors and support healing in chronic wounds with scalable manufacturing potential.
Autologous blood-derived patch prepared at point of care
A therapy workflow for preparing an autologous blood patch at point of care by healthcare professionals for application to chronic wounds.
Services
Contract manufacturing and technology transfer for cell therapies
Provision or coordination of manufacturing assets and technology transfer to support production of cell therapy products and scale-up towards clinical/commercial supply.
Academic and industrial collaboration for product development
Strategic collaborations with academic hospitals and industry partners to manufacture and advance advanced wound therapies into clinical use.
Contract manufacturing and technology transfer for cell therapies
Provision or coordination of manufacturing assets and technology transfer to support production of cell therapy products and scale-up towards clinical/commercial supply.
Academic and industrial collaboration for product development
Strategic collaborations with academic hospitals and industry partners to manufacture and advance advanced wound therapies into clinical use.
Expertise Areas
- Cell therapy development for wound healing
- Wound healing therapeutics and clinical pipeline management
- Enzymatic debridement development
- Bioprocessing and manufacturing scale-up (CMC) for cell therapies
Key Technologies
- Autologous and allogeneic cell-based therapeutics
- Epidermal cell grafting
- Cell spray delivery formats
- Enzymatic debridement agents